
Sign up to save your podcasts
Or
We discuss the US Food & Drug Administration's black box warning for droperidol and the evidence behind this warning.
We then discuss the use of butyrophenones such as droperidol and haloperidol for the treatment of agitation, headaches, nausea and vomiting, and gastroparesis/cannabinoid hyperemesis.
Thanks for listening! Jeremy Faust and Lauren Westafer
4.7
275275 ratings
We discuss the US Food & Drug Administration's black box warning for droperidol and the evidence behind this warning.
We then discuss the use of butyrophenones such as droperidol and haloperidol for the treatment of agitation, headaches, nausea and vomiting, and gastroparesis/cannabinoid hyperemesis.
Thanks for listening! Jeremy Faust and Lauren Westafer
1,864 Listeners
538 Listeners
385 Listeners
251 Listeners
104 Listeners
808 Listeners
3,336 Listeners
257 Listeners
257 Listeners
1,095 Listeners
694 Listeners
519 Listeners
249 Listeners
366 Listeners
233 Listeners